Polypharmacy and Dynapenia in Older Adults Undergoing Rehabilitation After Fracture or Elective Orthopedic Surgery

<i>Background and Objectives</i>: Polypharmacy is common among older adults and its impact on the onset of dynapenia, reduced muscle strength and function, is largely unknown. Older adults hospitalized for either post-fracture or elective orthopedic surgery (knee, femur, or hip) and undergoing rehabilitation were included to investigate the association between polypharmacy and dynapenia. A further aim is to investigate associations between polypharmacy and dynapenia with outcomes including mortality, falls, and hospitalizations. <i>Materials and Methods</i>: On the fifth day following surgery, medical doctors administered a structured questionnaire along with physical and instrumental assessments. Polypharmacy was defined as the concurrent and regular use of 5 or more medications, dynapenia was assessed by measuring handgrip strength. The association between dynapenia and polypharmacy was detected with logistic regression, and their impact on adverse outcomes was assessed using Cox models, Kaplan-Meier curves and log-rank tests. <i>Results</i>: A total of 205 older adults (mean age 77.5 years; 79.5% women) were enrolled. After adjusting for sex, age, and the presence of multidimensional frailty, dynapenia was significantly associated with increased adverse outcomes such as mortality, falls, and hospitalizations (HR 2.96, 95% CI 1.22-7.20, <i>p</i> = 0.016). Similarly, polypharmacy was independently linked to a higher risk of mortality, falls and hospitalizations (HR 2.23, 95% CI 1.24-4.10, <i>p</i> = 0.007). At 6 months follow-up, polypharmacy showed a strong and significant association with dynapenia (adjusted OR 2.63, 95% CI 1.21-4.63, <i>p</i> = 0.019). <i>Conclusions</i>: These findings suggest that polypharmacy is strongly associated with dynapenia, both conditions are associated with adverse clinical outcomes in older hospitalized patients. Close monitoring and tailored interventions are recommended to mitigate these risks and improve rehabilitation outcomes in this vulnerable population.

Authors

Institutions

Publication Details

Journal
Medicina
Published
2025-12-19
DOI
https://doi.org/10.3390/medicina62010006
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Polypharmacy and Dynapenia in Older Adults Undergoing Rehabilitation After Fracture or Elective Orthopedic Surgery

Pietro Cataldo, Ligia J. Domínguez, Francesco Saverio Ragusa, Nicola Veronese et al.
Medicina
Pharmaceutical Practices and Patient Outcomes
article

Polypharmacy and Dynapenia in Older Adults Undergoing Rehabilitation After Fracture or Elective Orthopedic Surgery

Pietro Cataldo, Ligia J. Domínguez, Francesco Saverio Ragusa, Nicola Veronese, Carlo Saccaro, Mario Barbagallo, Lee Smith, Pasquale Mansueto, Alessandro D’Aleo
article en

Abstract

<i>Background and Objectives</i>: Polypharmacy is common among older adults and its impact on the onset of dynapenia, reduced muscle strength and function, is largely unknown. Older adults hospitalized for either post-fracture or elective orthopedic surgery (knee, femur, or hip) and undergoing rehabilitation were included to investigate the association between polypharmacy and dynapenia. A further aim is to investigate associations between polypharmacy and dynapenia with outcomes including mortality, falls, and hospitalizations. <i>Materials and Methods</i>: On the fifth day following surgery, medical doctors administered a structured questionnaire along with physical and instrumental assessments. Polypharmacy was defined as the concurrent and regular use of 5 or more medications, dynapenia was assessed by measuring handgrip strength. The association between dynapenia and polypharmacy was detected with logistic regression, and their impact on adverse outcomes was assessed using Cox models, Kaplan-Meier curves and log-rank tests. <i>Results</i>: A total of 205 older adults (mean age 77.5 years; 79.5% women) were enrolled. After adjusting for sex, age, and the presence of multidimensional frailty, dynapenia was significantly associated with increased adverse outcomes such as mortality, falls, and hospitalizations (HR 2.96, 95% CI 1.22-7.20, <i>p</i> = 0.016). Similarly, polypharmacy was independently linked to a higher risk of mortality, falls and hospitalizations (HR 2.23, 95% CI 1.24-4.10, <i>p</i> = 0.007). At 6 months follow-up, polypharmacy showed a strong and significant association with dynapenia (adjusted OR 2.63, 95% CI 1.21-4.63, <i>p</i> = 0.019). <i>Conclusions</i>: These findings suggest that polypharmacy is strongly associated with dynapenia, both conditions are associated with adverse clinical outcomes in older hospitalized patients. Close monitoring and tailored interventions are recommended to mitigate these risks and improve rehabilitation outcomes in this vulnerable population.

MedicinaVol. 62(1)
Università degli Studi di Enna Kore (IT), Saint Camillus International University of Health and Medical Sciences (IT), Biruni University (TR), University of Palermo (AR), Anglia Ruskin University (GB), University of Palermo (IT)
Openalex Percentile: Top 49%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.